Hrom and Rouhbakhsh featured in Hattiesburg American, Clarion Ledger
John “Bo” Hrom, MD, with Hattiesburg Clinic Hematology/Oncology, and Rambod A. Rouhbakhsh, MD, with Hattiesburg Clinic MediSync® Clinical Research, were featured on the front page of the Hattiesburg American and The Clarion Ledger for their involvement in the ongoing COVID-19 clinical trials.
The clinic has joined two nationwide clinical trial programs. Dr. Hrom is leading the COVID-19 Expanded Access Program, a clinical trial for treating seriously ill patients through convalescent plasma therapy, while Dr. Rouhbakhsh is conducting the COVID-19 vaccination trial which aims to prevent infection by utilizing new technologies.
Follow the link to read the full story: https://bit.ly/2EfVYS6